Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
Caterpillar (CAT) Delivers Record $20.5 Billion Quarter on +24% Sales Growth

Caterpillar (CAT) Delivers Record $20.5 Billion Quarter on +24% Sales Growth

Key Takeaways

  • Caterpillar posted its first $20 billion quarter in company history, with sales and revenues reaching $20.5 billion, up 24% year-over-year and handily beating Wall Street's consensus estimate of approximately $19.3 billion.
  • Adjusted earnings per share surged 73% to $8.17, far exceeding the analyst consensus of roughly $6.19–$6.25 per share, while GAAP (Generally Accepted Accounting Principles) EPS climbed to $7.77 from $4.62 a year ago.
  • The order backlog swelled to $72 billion, a 92% year-over-year increase, reflecting robust demand across construction, mining, and power generation end markets with visibility extending into 2030.
  • All three primary segments posted double-digit sales growth, led by Construction Industries up 35%, Power & Energy up 17%, and Resource Industries up 20%, underscoring broad-based momentum.
  • Full-year guidance was raised, with management now projecting mid- to high-teens sales growth and improved margin and free cash flow expectations for 2026.
  • Shares jumped more than 8% in premarket trading following the release, reflecting strong investor approval of the blowout results and raised outlook.

Putting the Results in Context

Caterpillar's second-quarter 2026 results landed at a pivotal moment for the industrial sector. The company entered the quarter with elevated expectations, driven by booming AI data center construction that has turbocharged demand for its power generation equipment, large reciprocating engines, and turbines. A record backlog of roughly $63 billion at the start of Q2 placed an execution premium on the company's ability to convert orders into delivered revenue. At the same time, tariff-related cost headwinds, a recent analyst downgrade tied to data center regulatory risks, and mixed results from machinery peers all added complexity to the setup. These results were viewed as a critical test of whether Caterpillar's data center-driven growth story could continue to outrun cyclical pressures in its traditional construction, mining, and agricultural equipment markets. I also checked this using Tickeron's AI Screener to see how CAT compares to others in the industry.

Breaking Down the Numbers

Caterpillar reported second-quarter 2026 sales and revenues of $20.5 billion, representing a 24% increase from $16.6 billion in the prior-year period and marking the first time the company has crossed the $20 billion threshold in a single quarter. The result comfortably exceeded the Wall Street consensus estimate of roughly $19.3 billion. Higher sales volume contributed $3.1 billion to the top line, while favorable price realization added $595 million.

On the bottom line, GAAP profit per share reached $7.77, up from $4.62 in Q2 2025. Adjusted earnings per share (EPS), which excludes restructuring costs, came in at $8.17 — a 73% increase from $4.72 a year ago and a substantial beat against analyst estimates clustered around $6.19 to $6.25. Operating profit rose 50% to $4.3 billion, while the adjusted operating profit margin expanded by 430 basis points to 21.9%, compared with 17.6% in the prior-year quarter.

Segment-level performance showed strength across the board. Construction Industries sales jumped 35% to $8.3 billion, fueled by higher equipment sales to end users in North America, where sales alone surged 50%. Power & Energy segment sales climbed 17% to $8.2 billion, with power generation sales up 29%, largely driven by data center demand for large reciprocating engines and turbines. Resource Industries sales rose 20% to $4.6 billion, supported by mining equipment and rail sector deliveries. Financial Products revenues increased 10% to $1.1 billion, with segment profit up 32% to $328 million.

Machinery, Energy & Transportation (ME&T) free cash flow hit a record $5.1 billion in the quarter, roughly $2.8 billion higher than the prior year. The company deployed $2.2 billion of cash for share repurchases ($1.5 billion) and dividends ($0.7 billion), ending the quarter with $6.7 billion in enterprise cash. Tariff costs totaled approximately $400 million, down from a prior estimate of $700 million, though IEEPA (International Emergency Economic Powers Act) tariff recoveries contributed about $0.65 per share to both GAAP and adjusted EPS. From what I see, the broad segment strength stands out here.

How the Market Reacted

The market responded decisively to Caterpillar's Q2 report. Shares surged more than 8% in premarket trading on August 4, briefly touching $904 before settling at approximately $877 by the close — a 5.4% gain on the day. The rally reflected more than just the headline beat. Investors appeared to take comfort in several reinforcing signals: the broad-based nature of growth across all three primary segments rather than reliance on a single business line, the dramatic expansion of the backlog to $72 billion, and management's confidence in raising full-year guidance. Sentiment had been cautious heading into the print following a Baird downgrade the prior week tied to data center regulatory risks and a nearly 7% share-price pullback. The emphatic beat and raised outlook effectively reset the narrative, at least in the near term, reaffirming the thesis that CAT remains a prime beneficiary of AI infrastructure spending without being solely dependent on it.

What to Watch Going Forward

With management raising its full-year 2026 outlook to mid- to high-teens sales growth and signaling improved margins and free cash flow, the attention now shifts to sustainability. The record $72 billion backlog provides exceptional revenue visibility, with some orders extending as far out as 2030, but the pace at which this backlog converts into delivered revenue will be closely watched in coming quarters. Supply chain capacity, particularly in large engine and turbine production, remains a key variable.

Tariff dynamics also warrant monitoring. While Q2 tariff costs of $400 million came in below the prior estimate of $700 million, trade policy remains fluid and IEEPA-related recoveries may not recur at the same level. Investors will likely scrutinize whether margin expansion — to 21.9% on an adjusted basis — is durable or partly aided by one-time factors. I’m watching this closely with the help of Tickeron’s AI Trend Prediction Engine to track momentum signals.

The data center demand story, a central pillar of Caterpillar's recent valuation expansion, faces its own crosscurrents. Regulatory and environmental permitting challenges around large-scale data center projects have drawn increasing attention, and any slowdown in hyperscale infrastructure approvals could temper growth expectations for the Power & Energy segment. Conversely, Caterpillar's decision to resume production of its 10-megawatt gas reciprocating engine platform signals confidence in sustained demand.

Finally, the health of Caterpillar's customer base offers a reassuring undercurrent. Past dues fell to 1.31%, the lowest level since 1998, and the allowance rate hit a record low of 0.84%, indicating strong customer financial health. As long as end-user demand remains robust and dealer inventories stay balanced, CAT enters the second half of 2026 with considerable operating momentum.

Using AI Tools in My Research Process

In my own work analyzing earnings and sector trends, I regularly turn to Tickeron’s AI Screener to quickly filter for stocks showing similar momentum or strong fundamentals within the industrials space. It helps streamline the process of spotting patterns and comparing performance metrics across thousands of names, saving time while highlighting ideas worth deeper review. The tool integrates technical signals, industry filters, and AI-driven insights in a way that complements traditional fundamental analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CAT

CAT's RSI Oscillator ascends from oversold territory

The RSI Indicator for CAT moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In of the 26 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where CAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAT advanced for three days, in of 380 cases, the price rose further within the following month. The odds of a continued upward trend are .

CAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CAT as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CAT turned negative on July 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

CAT moved below its 50-day moving average on July 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CAT crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CAT entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CAT's P/B Ratio (20.833) is very high in comparison to the industry average of (3.169). P/E Ratio (37.749) is within average values for comparable stocks, (42.363). Projected Growth (PEG Ratio) (2.056) is also within normal values, averaging (1.841). Dividend Yield (0.007) settles around the average of (0.013) among similar stocks. CAT's P/S Ratio (5.479) is very high in comparison to the industry average of (1.230).

Notable companies

The most notable companies in this group are Caterpillar (NYSE:CAT), Deere & Company (NYSE:DE).

Industry description

The industry designs and builds agricultural, construction and other large commercial and transportation equipment. Tractors, planters and harvesters, as well as rock-crushing, railroad, demolition and other construction implements are produced by this industry. Rapid urbanization and industrialization has been bolstering the expansion of the construction sector in the past few decades, thereby boosting demand for heavy equipment businesses. Caterpillar Inc., Deere & Company and Cummins Inc (Ex. Cummins Engine Inc) are some prominent companies in this industry.

Market Cap

The average market capitalization across the Trucks/Construction/Farm Machinery Industry is 29.33B. The market cap for tickers in the group ranges from 223.29K to 403.73B. CAT holds the highest valuation in this group at 403.73B. The lowest valued company is OSRS at 223.29K.

High and low price notable news

The average weekly price growth across all stocks in the Trucks/Construction/Farm Machinery Industry was 8%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 2%. HYFM experienced the highest price growth at 183%, while AGCO experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Trucks/Construction/Farm Machinery Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was -1% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 51
Price Growth Rating: 54
SMR Rating: 79
Profit Risk Rating: 79
Seasonality Score: -57 (-100 ... +100)
View a ticker or compare two or three
CAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of mining equipment, diesel and natural gas engines and industrial gas turbines

Industry TrucksConstructionFarmMachinery

Profile
Details
Industry
Trucks Or Construction Or Farm Machinery
Address
5205 N. O'Connor Boulevard
Phone
+1 972 891-7700
Employees
113200
Web
https://www.caterpillar.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.